Global Information Inc. would like to present a new market research report, "Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" by GlobalData.
The US is the largest market for FFDM equipment and contributed 51% of the global revenues in 2010. The US market was valued at $407.2m and is forecast to reach $713.9m in 2017 at a CAGR of 8%.
GlobalData estimates the global Full-Field Digital Mammography (FFDM) equipment market to reach $1.3 billion in 2017 from $801.2m in 2010 at a Compound Annual Growth Rate (CAGR) of 8%. The market is primarily driven by technological advances and increase in reimbursement. The US Food and Drug Administration (FDA) reclassification of FFDM devices from class III to class II is expected to make it easier for companies to get clearance for new devices. New equipment can be cleared for marketing in the US through FDAs 510k process which requires new devices to match the safety and efficacy of previously approved products. This will provide relief for companies as they do not have to go through the PMA process for the approval of new products. The companies will be able to launch new products without delay and this allows vendors to provide more options for purchase. The reclassification will also enable new companies to enter the market which will increase competition. The FDA approvals for FFDM systems from Hologic, GE Healthcare and Siemens Healthcare in 2011 is expected to further intensify the competition, in turn providing cost effective solutions for the customers.
A combination of other modalities such as ultrasound and Magnetic Resonance Imaging (MRI) with mammography for improved breast cancer detection is also expected to drive the market growth. Film-screen mammography systems will continue to be replaced with FFDM systems to meet high patient volume and for improvement in the detection of breast cancer.
Hologic, Inc held 52% of the market share in the global FFDM market in 2010. The Selenia Dimensions FFDM is a widely preferred device for breast cancer detection. Positive clinical evidence on sensitivity, specificity and breast compression has provided Hologic with an edge over its competitors in the market.
GE Healthcare (27%) and Siemens Healthcare (10%) are other key players in the market. Hologic dominates the US market with a share of about 70% while GE Healthcare is one of the dominant players in the Asia-Pacific market. Siemens Healthcare has a significant presence in Europe. Hologic is expected to strengthen its lead with the FDAs approval for Selenia Dimensions Breast Tomosynthesis (3D) system in 2011. GE Healthcare and Siemens Healthcare have also received FDA clearance for new FFDM systems in 2011. Philips Healthcare is expected to improve its presence in the global FFDM market with the acquisition of Sectra AB in 2011.
About the Report
GlobalDatas new report, "Full-Field Digital Mammography Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global full-field digital mammography equipment market. The report provides market landscape, competitive landscape and market trends information on the full-field digital mammography equipment market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the markets dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalDatas team of industry experts.